DrugPatentWatch Database Preview
Profile for United States of America Patent: 2005239777
US Patent Family Members and Approved Drugs for United States of America Patent: 2005239777
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Jun 27, 2022 | Genzyme Corp | CAPRELSA | vandetanib |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |